Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor VIII (FVIII) Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Not applicableLooking for participantsNCT06550882
What this trial is testing

OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

Who this might be right for
Acquired Hemophilia A
Takeda 9
Testing effectiveness (Phase 2)Study completedNCT00055341
What this trial is testing

Treatment of Hepatitis C in Hemophilic Patients With HIV

Who this might be right for
HIV InfectionsHepatitis CHemophilia
National Institute of Allergy and Infectious Diseases (NIAID) 22
Large-scale testing (Phase 3)Study completedNCT00157040
What this trial is testing

Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 50
Post-approval studies (Phase 4)Study completedNCT01800435
What this trial is testing

A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor

Who this might be right for
Hereditary Factor VIII Deficiency Disease With Inhibitor
Oslo University Hospital 6
Not applicableStudy completedNCT03199794
What this trial is testing

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

Who this might be right for
Acquired Hemophilia A
Baxalta now part of Shire 50
Large-scale testing (Phase 3)Study completedNCT00162019
What this trial is testing

Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients

Who this might be right for
Hemophilia A
Baxalta now part of Shire 56
Not applicableStudy completedNCT03034044
What this trial is testing

Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe

Who this might be right for
Factor VIII Deficiency, CongenitalFactor 8 Deficiency, CongenitalAutosomal Hemophilia A+2 more
Pfizer 106
Not applicableStudy completedNCT02190149
What this trial is testing

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 64
Early research (Phase 1)Study completedNCT05651061
What this trial is testing

A Phase I of SS109 in Hemophilia A or and B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 27
Large-scale testing (Phase 3)Study completedNCT04161495
What this trial is testing

Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A

Who this might be right for
Factor VIII Deficiency
Bioverativ, a Sanofi company 159